Search Results Search Sort by RelevanceMost Recent State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711. Medical Education Apr 2021 How Should Trainees Be Taught to Have Compassionate Intention When Force Is Necessary to Care Well for Patients? Christopher G. AhnAllen, PhD Trainees are expected to encounter clinical training environments and situations that utilize force methods. AMA J Ethics. 2021;23(4):E318-325. doi: 10.1001/amajethics.2021.318. Viewpoint Jan 2022 How Medical-Dental EHR Integration Can Improve Diabetes Care Neel Shimpi, BDS, MM, PhD, Elizabeth Buchanan, PhD, and Amit Acharya, BDS, MS, PhD Poor oral health has been neglected as a public health threat, despite recognition as “epidemic” in scale by the US Office of the Surgeon General. AMA J Ethics. 2022;24(1):E99-105. doi: 10.1001/amajethics.2022.99. Case and Commentary Jan 2016 What’s the Role of Autonomy in Patient- and Family-Centered Care When Patients and Family Members Don’t Agree? Laura Sedig, MD When family members disagree with a patient about care planning, the physician might be able to facilitate a resolution. AMA J Ethics. 2016;18(1):12-17. doi: 10.1001/journalofethics.2017.18.1.ecas2-1601. Policy Forum Nov 2017 Using Principles of Co-Production to Improve Patient Care and Enhance Value Puja Turakhia, MS and Brandon Combs, MD Improving health outcomes through patient-centered care is one way to build value for stakeholders in health care. AMA J Ethics. 2017;19(11):1125-1131. doi: 10.1001/journalofethics.2017.19.11.pfor1-1711. Medicine and Society Jun 2021 Historical Trauma and Descendants’ Well-Being Reeya A. Patel, MS and Donna K. Nagata, PhD This article addresses intergenerational trauma transmission, focusing on Japanese American and Southeast Asian American communities. AMA J Ethics. 2021;23(6):E487-493. doi: 10.1001/amajethics.2021.487. Case and Commentary Jul 2021 When Symptoms Aren’t Visible or Measurable, How Should Disability Be Assessed? Cerise L. Glenn, PhD Patients writing daily journal briefs about work-related activities and pain can help clinicians help them. AMA J Ethics. 2021;23(7):E514-518. doi: 10.1001/amajethics.2021.514. Case and Commentary Jul 2021 How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers? Benjamin Tolchin, MD, MS, Dorothy W. Tolchin, MD, EdM, and Michael Ashley Stein, JD, PhD Public and self-stigma negatively influence patients’ quality of life, employment, and housing opportunities. AMA J Ethics. 2021;23(7):E530-536. doi: 10.1001/amajethics.2021.530. Medicine and Society Jul 2021 Questioning Biomedicine’s Privileging of Disease and Measurability Camille Kroll, MA Adhering too strictly to biomedical thinking about diagnosis can prevent clinicians from empathically engaging with patients and helping them navigate their illness experiences. AMA J Ethics. 2021;23(7):E537-541. doi: 10.1001/amajethics.2021.537. Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711.
Medical Education Apr 2021 How Should Trainees Be Taught to Have Compassionate Intention When Force Is Necessary to Care Well for Patients? Christopher G. AhnAllen, PhD Trainees are expected to encounter clinical training environments and situations that utilize force methods. AMA J Ethics. 2021;23(4):E318-325. doi: 10.1001/amajethics.2021.318.
Viewpoint Jan 2022 How Medical-Dental EHR Integration Can Improve Diabetes Care Neel Shimpi, BDS, MM, PhD, Elizabeth Buchanan, PhD, and Amit Acharya, BDS, MS, PhD Poor oral health has been neglected as a public health threat, despite recognition as “epidemic” in scale by the US Office of the Surgeon General. AMA J Ethics. 2022;24(1):E99-105. doi: 10.1001/amajethics.2022.99.
Case and Commentary Jan 2016 What’s the Role of Autonomy in Patient- and Family-Centered Care When Patients and Family Members Don’t Agree? Laura Sedig, MD When family members disagree with a patient about care planning, the physician might be able to facilitate a resolution. AMA J Ethics. 2016;18(1):12-17. doi: 10.1001/journalofethics.2017.18.1.ecas2-1601.
Policy Forum Nov 2017 Using Principles of Co-Production to Improve Patient Care and Enhance Value Puja Turakhia, MS and Brandon Combs, MD Improving health outcomes through patient-centered care is one way to build value for stakeholders in health care. AMA J Ethics. 2017;19(11):1125-1131. doi: 10.1001/journalofethics.2017.19.11.pfor1-1711.
Medicine and Society Jun 2021 Historical Trauma and Descendants’ Well-Being Reeya A. Patel, MS and Donna K. Nagata, PhD This article addresses intergenerational trauma transmission, focusing on Japanese American and Southeast Asian American communities. AMA J Ethics. 2021;23(6):E487-493. doi: 10.1001/amajethics.2021.487.
Case and Commentary Jul 2021 When Symptoms Aren’t Visible or Measurable, How Should Disability Be Assessed? Cerise L. Glenn, PhD Patients writing daily journal briefs about work-related activities and pain can help clinicians help them. AMA J Ethics. 2021;23(7):E514-518. doi: 10.1001/amajethics.2021.514.
Case and Commentary Jul 2021 How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers? Benjamin Tolchin, MD, MS, Dorothy W. Tolchin, MD, EdM, and Michael Ashley Stein, JD, PhD Public and self-stigma negatively influence patients’ quality of life, employment, and housing opportunities. AMA J Ethics. 2021;23(7):E530-536. doi: 10.1001/amajethics.2021.530.
Medicine and Society Jul 2021 Questioning Biomedicine’s Privileging of Disease and Measurability Camille Kroll, MA Adhering too strictly to biomedical thinking about diagnosis can prevent clinicians from empathically engaging with patients and helping them navigate their illness experiences. AMA J Ethics. 2021;23(7):E537-541. doi: 10.1001/amajethics.2021.537.
Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.